Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230980 · ClinicalTrials.gov registry record · Phase 3
Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery
A Phase 3 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 3
- Development phase
- 74
- Enrollment target
NCT04230980 is a Phase 3 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 74 participants.
The verdict
NCT04230980, a Phase 3 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 74 participants
- Enrollment target
Study Summary
The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.
Interventions
- DRUG Placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2022-12-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04230980
The ClinicalTrials.gov registry entry for NCT04230980 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04230980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04230980 about?
NCT04230980 is a clinical study titled "Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery". The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period redu...
What is the current status of trial NCT04230980?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 74 participants. The study started on 2020-07-28. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT04230980?
The interventions under investigation include: Placebo (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04230980?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.